Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia
1 other identifier
interventional
200
1 country
1
Brief Summary
The primary objective is to determine if early infectious disease (ID) consultation (defined as within 48 hours of a positive blood culture) will reduce mortality rates from Staphylococcus aureus bacteremia (SAB). This study will also determine if such consultations could reduce the duration of hospitalisation, recurrence and financial costs in patients with this infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 13, 2008
CompletedFirst Posted
Study publicly available on registry
February 25, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJanuary 7, 2014
January 1, 2014
8.2 years
February 13, 2008
January 6, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mortality
1 year
Secondary Outcomes (3)
recurrence
2 year
duration of hospitalisation
1 year
financial costs of hospitalisation
1 year
Study Arms (2)
ID
ACTIVE COMPARATORPatients receiving an early Infectious disease consultation ( within first 48 hours of a positive blood culture)
NO ID
NO INTERVENTIONIncludes those patients who do not receive an Infectious disease consultation in the first 48 hours
Interventions
Randomised trial to determine the utility of an early Infectious disease Consultation in Staphylococcus aureus bacteremic patients ( in the first 48 hours of a positive blood culture)
Eligibility Criteria
You may qualify if:
- All inpatients at the National University Hospital with Staphylococcus aureus (both methicillin sensitive and methicillin resistant) bacteremia isolated within the defined time period
You may not qualify if:
- Patients who died or were discharged before the notification from the laboratory
- Neonates
- Polymicrobial bacteremia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital
Singapore, 11974, Singapore
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul A Tambyah, MD
National University of Singapore
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Paul Ananth Tambyah
Study Record Dates
First Submitted
February 13, 2008
First Posted
February 25, 2008
Study Start
October 1, 2007
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
January 7, 2014
Record last verified: 2014-01